日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii

美罗培南-ANT3310 是一种独特的 β-内酰胺-β-内酰胺酶抑制剂组合,具有扩大的抗菌谱,可对抗革兰氏阴性病原体,包括耐卡巴培南的鲍曼不动杆菌

Magdalena Zalacain, Pauline Achard, Agustina Llanos, Ian Morrissey, Stephen Hawser, Kirsty Holden, Eleanor Toomey, David Davies, Simon Leiris, Carole Sable, Adeline Ledoux, Justine Bousquet, Jérôme Castandet, Clarisse Lozano, Martin Everett, Marc Lemonnier

Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales

新型特异性金属-β-内酰胺酶抑制剂 ANT2681 将美罗培南活性恢复至针对 NDM 阳性肠杆菌的临床有效水平

Magdalena Zalacain, Clarisse Lozano, Agustina Llanos, Nicolas Sprynski, Thomas Valmont, Cyntia De Piano, David Davies, Simon Leiris, Carole Sable, Adeline Ledoux, Ian Morrissey, Marc Lemonnier, Martin Everett